NEW YORK (Reuters Health) May 17 –
In women older than 39 years who are undergoing in vitro fertilization (IVF), addition of a midcycle GnRH antagonist to the ovarian stimulation regimen increases the rate of oocyte retrieval, physicians in New York report, although whether clinical outcomes are improved by this change is unclear.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!